Daichi Fujimoto, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Plaque, Atherosclerotic | 14 | 2024 | 1549 | 2.030 |
Why?
|
Coronary Vessels | 16 | 2024 | 3114 | 1.510 |
Why?
|
Coronary Artery Disease | 17 | 2024 | 6573 | 1.450 |
Why?
|
Tomography, Optical Coherence | 17 | 2024 | 2954 | 1.270 |
Why?
|
Coronary Angiography | 17 | 2024 | 4525 | 0.950 |
Why?
|
Acute Coronary Syndrome | 7 | 2024 | 2193 | 0.630 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2024 | 757 | 0.580 |
Why?
|
Brain Infarction | 1 | 2018 | 285 | 0.540 |
Why?
|
Pneumocystis carinii | 1 | 2014 | 72 | 0.440 |
Why?
|
Predictive Value of Tests | 8 | 2024 | 15424 | 0.420 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1337 | 0.410 |
Why?
|
Catheter Ablation | 2 | 2022 | 2787 | 0.370 |
Why?
|
Rupture, Spontaneous | 3 | 2024 | 365 | 0.330 |
Why?
|
Pneumonia | 1 | 2021 | 2159 | 0.320 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2022 | 348 | 0.300 |
Why?
|
Retrospective Studies | 20 | 2024 | 81659 | 0.280 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2018 | 2186 | 0.260 |
Why?
|
Venous Thromboembolism | 1 | 2018 | 1883 | 0.250 |
Why?
|
Adipose Tissue | 3 | 2024 | 3324 | 0.220 |
Why?
|
Mammary Arteries | 1 | 2024 | 82 | 0.220 |
Why?
|
Atherectomy, Coronary | 1 | 2023 | 138 | 0.210 |
Why?
|
Risk Factors | 9 | 2024 | 74886 | 0.200 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5389 | 0.200 |
Why?
|
Serpins | 1 | 2024 | 246 | 0.200 |
Why?
|
Neutrophils | 1 | 2014 | 3779 | 0.190 |
Why?
|
Heart Septum | 1 | 2022 | 304 | 0.180 |
Why?
|
Treatment Outcome | 11 | 2024 | 65295 | 0.180 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11872 | 0.170 |
Why?
|
Chemokines | 1 | 2024 | 963 | 0.170 |
Why?
|
Severity of Illness Index | 4 | 2024 | 15925 | 0.170 |
Why?
|
Aged | 15 | 2024 | 171319 | 0.150 |
Why?
|
Lipids | 3 | 2024 | 3322 | 0.150 |
Why?
|
Lipoproteins, HDL | 1 | 2022 | 679 | 0.140 |
Why?
|
Angioplasty, Balloon | 1 | 2021 | 592 | 0.140 |
Why?
|
Drug-Eluting Stents | 1 | 2023 | 681 | 0.140 |
Why?
|
Japan | 1 | 2021 | 1418 | 0.130 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13491 | 0.130 |
Why?
|
Coronary Stenosis | 1 | 2022 | 803 | 0.130 |
Why?
|
Lung Diseases, Interstitial | 1 | 2024 | 940 | 0.120 |
Why?
|
Cholesterol, HDL | 1 | 2022 | 1816 | 0.120 |
Why?
|
Humans | 28 | 2024 | 767040 | 0.120 |
Why?
|
Middle Aged | 13 | 2024 | 223233 | 0.120 |
Why?
|
Coronary Artery Bypass | 1 | 2023 | 2189 | 0.110 |
Why?
|
Risk Assessment | 3 | 2024 | 24299 | 0.110 |
Why?
|
Cryosurgery | 1 | 2018 | 479 | 0.110 |
Why?
|
Video Recording | 1 | 2018 | 977 | 0.100 |
Why?
|
Male | 15 | 2024 | 364203 | 0.100 |
Why?
|
Heart Conduction System | 1 | 2018 | 1008 | 0.100 |
Why?
|
Cholesterol | 1 | 2022 | 2905 | 0.100 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2014 | 242 | 0.100 |
Why?
|
Pulmonary Veins | 1 | 2018 | 761 | 0.100 |
Why?
|
Female | 14 | 2024 | 396660 | 0.090 |
Why?
|
Surgery, Computer-Assisted | 1 | 2018 | 996 | 0.090 |
Why?
|
Positive-Pressure Respiration | 1 | 2014 | 713 | 0.080 |
Why?
|
Echocardiography | 1 | 2022 | 5042 | 0.080 |
Why?
|
Cytokines | 1 | 2024 | 7446 | 0.080 |
Why?
|
Prognosis | 5 | 2024 | 29963 | 0.080 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5886 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2024 | 3418 | 0.070 |
Why?
|
Prevalence | 1 | 2024 | 15851 | 0.070 |
Why?
|
Disease Progression | 1 | 2024 | 13646 | 0.070 |
Why?
|
Phenotype | 1 | 2024 | 16718 | 0.060 |
Why?
|
Registries | 1 | 2022 | 8351 | 0.060 |
Why?
|
Chemokine CCL11 | 1 | 2024 | 128 | 0.060 |
Why?
|
Inflammation | 4 | 2024 | 10869 | 0.060 |
Why?
|
Time Factors | 2 | 2024 | 40154 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2024 | 11513 | 0.050 |
Why?
|
Incidence | 1 | 2021 | 21526 | 0.050 |
Why?
|
Chemokine CCL2 | 1 | 2024 | 605 | 0.050 |
Why?
|
Interleukin-8 | 1 | 2024 | 704 | 0.050 |
Why?
|
Prospective Studies | 2 | 2023 | 54886 | 0.050 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2024 | 892 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39317 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2014 | 5345 | 0.040 |
Why?
|
Survival Rate | 1 | 2014 | 12823 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2018 | 5180 | 0.040 |
Why?
|
Popliteal Artery | 1 | 2021 | 313 | 0.040 |
Why?
|
Angioplasty | 1 | 2021 | 355 | 0.040 |
Why?
|
Air | 1 | 2018 | 186 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 1104 | 0.040 |
Why?
|
Fibrosis | 1 | 2024 | 2078 | 0.030 |
Why?
|
Placenta | 1 | 2024 | 1726 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2024 | 3227 | 0.030 |
Why?
|
Ultrasonography, Interventional | 1 | 2021 | 1523 | 0.030 |
Why?
|
Heart Atria | 1 | 2018 | 1362 | 0.020 |
Why?
|
Heart | 1 | 2024 | 4429 | 0.020 |
Why?
|
Equipment Design | 1 | 2018 | 3489 | 0.020 |
Why?
|
Proteomics | 1 | 2024 | 3913 | 0.020 |
Why?
|
Chronic Disease | 1 | 2024 | 9362 | 0.020 |
Why?
|
Pregnancy | 1 | 2024 | 30238 | 0.010 |
Why?
|
Adult | 1 | 2014 | 223317 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 59548 | 0.010 |
Why?
|